Emergency medical services naloxone access: A national systematic legal review

Academic Emergency Medicine

Volumn 21, Issue 10, 2014, Pages 1173-1177

  Davis, Corey S ^a   Southwell, Jessica K ^b   Niehaus, Virginia Radford ^a   Walley, Alexander Y ^c   Dailey, Michael W ^d  

^a Network for Public Health Law Southeastern Region   (United States)

^b IL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ALBANY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE; OPIATE; NARCOTIC ANTAGONIST;

DRUG OVERDOSE; DRUG USE; EMERGENCY HEALTH SERVICE; GUAM; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; LEGAL ASPECT; PUERTO RICO; REVIEW; SYSTEMATIC REVIEW; UNITED STATES; CERTIFICATION; FEMALE; LEGISLATION AND JURISPRUDENCE; MALE; SUPPLY AND DISTRIBUTION;

CERTIFICATION; DRUG OVERDOSE; EMERGENCY MEDICAL SERVICES; FEMALE; GUAM; HUMANS; MALE; NALOXONE; NARCOTIC ANTAGONISTS; PUERTO RICO; UNITED STATES;

EID: 84908118490     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/acem.12485     Document Type: Review

References (34)

1. Paulozzi LJ, Weisler RH, Patkar AA. A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. J Clin Psychiatry 2011;72:589-92.
2. Jones CM, Mack KA, Paulozzi L. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013;309:657-9.
3. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women-United States, 1999-2010. MMWR Morbid Mortal Wkly Rep 2013;62:537-42.
4. Webster LR, Cochella S, Dasgupta N, et al. An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med 2011;12 (Suppl 2):S26-35.
5. Centers for Disease Control and Prevention. Acetyl fentanyl overdose fatalities-Rhode Island, March-May 2013. MMWR Morb Mortal Wkly Rep 2013;62:703-4.
6. Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend 2013;131:263-70.
7. Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend 2012;125:8-18.
8. Coben JH, Davis SM, Furbee PM, Sikora RD, Tillotson RD, Bossarte RM. Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med 2010;38:517-24.
9. Chamberlain JM, Klein BL. A comprehensive review of naloxone for the emergency physician. Am J Emerg Med 1994;12:650-60.
10. Kim D, Irwin KS, Khoshnood K. Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. Am J Public Health 2009;99:402-7.
11. Centers for Disease Control and Prevention. Com-munity- based opioid overdose prevention programs providing naloxone-United States, 2010. MMWR Morb Mortal Wkly Rep 2012;61:101-5.
12. Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 2013;346:f174.
13. Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol 2012;175:302-8.
14. Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis 2006;25:89-96.
15. Food and Drug Administration. FDA Approves New Hand-held Auto-injector to Reverse Opioid Overdose. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm391465.htm. Accessed Jul 18, 2014.
16. National Highway Traffic Safety Administration. National EMS Scope of Practice Model. Report No. DOT HS 810 657. Available at: http://www.ems.gov/education/EMSScope.pdf. Accessed Jul 18, 2014.
17. National Highway Traffic Safety Administration. EMS Workforce for the 21st Century: A National Assessment. Available at: http://healthandwelfare.idaho.gov/Portals/0/Medical/EMS/workforce-report-ems.pdf. Accessed Jul 18, 2014.
18. Rawlinson C, Crews P. Access to quality health services in rural areas emergency medical services: a literature review. In: Gamm LD, Hutchison LL, Dabney BJ, Dorsey AM (editors). Rural Healthy People 2010: A Companion Document to Healthy People 2010. Volume 1. College Station, TX: Texas A&M University System Health Science Center, School of Rural Public Health, Southwest Rural Health Research Center, 2003.
19. Burris S, Wagenaar AC, Swanson J, Ibrahim JK, Wood J, Mello MM. Making the case for laws that improve health: a framework for public health law research. Milbank Q 2010;88:169-210.
20. Clarke SF, Dargan PI, Jones AL. Naloxone in opioid poisoning: walking the tightrope. Emerg Med J 2005;22:612-6.
21. Cone DC. Knowledge translation in the emergency medical services: a research agenda for advancing prehospital care. Acad Emerg Med 2007;14:1052-7.
22. Belz D, Lieb J, Rea T, Eisenberg MS. Naloxone use in a tiered-response emergency medical services system. Prehosp Emerg Care 2006;10:468-71.
23. Ashton H, Hassan Z. Best evidence topic report. Intranasal naloxone in suspected opioid overdose. Emerg Med J 2006;23:221-3.
24. Barton ED, Colwell CB, Wolfe T, et al. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting. J Emerg Med 2005;29:265-71.
25. Barton ED, Ramos J, Colwell C, Benson J, Baily J, Dunn W. Intranasal administration of naloxone by paramedics. Prehosp Emerg Care 2002;6:54-8.
26. Network for Public Health Law. Legal Interventions to Reduce Overdose Mortality. Available at: https://www.networkforphl.org/-asset/qz5pvn/network-nal-oxone-10-4.pdf. Accessed Jul 18, 2014.
27. Davis C, Webb D, Burris S. Changing law from barrier to facilitator of opioid overdose prevention. J Law Med Ethics 2013;41(Suppl 1):33-6.
28. Doe-Simkins M, Walley AY, Epstein A, Moyer P. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health 2009;99:788-91.
29. Davis CS, Ruiz S, Glynn P, Picariello G, Walley AY. Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts. Am J Public Health 2014;104(8):e7-9.
30. Merlin MA, Saybolt M, Kapitanyan R, et al. Intranasal naloxone delivery is an alternative to intravenous naloxone for opioid overdoses. Am J Emerg Med 2010;28:296-303.
31. Kerr D, Kelly AM, Dietze P, Jolley D, Barger B. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction 2009;104:2067-74.
32. Osterwalder JJ. Naloxone-for intoxications with intravenous heroin and heroin mixtures-harmless or hazardous? A prospective clinical study. J Toxicol Clin Toxicol 1996;34:409-16.
33. Hsu W, Rao RB, Nelson LS. Naloxone hazards overstated. J Toxicol Clin Toxicol 1997;35(215-7):219-20.
34. National Highway Traffic Safety Administration. Progress on Evidence-Based Guidelines for Prehospital Emergency Care. Available at: http://www.ems.gov/pdf/2012/EBG-Project-Overview-Dec2011.pdf. Accessed Jul 17, 2014.